This video presents our new cGMP Lipid NanoParticle (LNP) manufacturing facility in Caponago, Italy. The FDA / EMA approved site builds on decades of sterile injectable experience and fully supplements our already existing LNP development capabilities.
The 900 m2 suite is state-of-the-art, Grade C throughout, fully-scalable, and offers process and purification scale-up. A full variety of nanoparticle assembly systems, notably Impingement Jets Mixing (IJM) by Knauer and NxGen Microfluidic technology by Cytiva, and a wide selection of purification technologies such as Ultrafiltration (UF), Diafiltration (DF) and Tangential Flow Filtration (TFF), together with comprehensive analytical services are available too.
As part of our fully-integrated offering CordenPharma additionally offers Aseptic Fill & Finish services conveniently located under the same roof, as well as a wide selection of functional Lipid Excipients provided within the CordenPharma facility network.
Dr. John Cameron
Global Platform Head Injectables
Related Articles
Want to find out more?
Get in touch with our team of experts to explore bespoke end-to-end CDMO support of your complete drug lifecycle
at any scale.